Oncolytic Virus Therapy Market Size And Share

  • Report Code : TIPRE00014846
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Oncolytic Virus Therapy Market Size - Trends by 2031

Buy Now

Oncolytic Virus Therapy Market Report Oncolytic Virus Therapy Market Scope and Analysis Oncolytic Virus Therapy Market Size and Share

Oncolytic Virus Therapy Market Report Analysis

Oncolytic Virus Therapy Market

  • CAGR (2025 - 2031)
    24.5%
  • Market Size 2024
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Amgen Inc
  • Oncolytics Biotech Inc
  • Merck Co Inc
  • Transgene
  • Oncolys BioPharma Inc
  • Targovax ASA
  • Vyriad Inc
  • Genelux Corporation
  • Sorrento Therapeutics Inc
  • Lokon Pharma AB

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

By Product Type
  • Vaccinia Virus-based Oncolytic Viruses
  • HSV-based Oncolytic Viruses
  • Adenoviruses-based Oncolytic Viruses
  • Newcastle Disease Virus-based Oncolytic Viruses
  • Vesicular Stomatitis Virus-based Oncolytic Viruses
By Application
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Melanoma
  • Brain Tumor
  • Blood Cancer
By End User
  • Hospitals
  • Specialty Clinics
  • Cancer Research Institutes